SCHEMBL1620602

SCHEMBL1620602

Cc1ccc(CBr)cc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
TSHR P16473 3/20 0.55
CYP3A4 P08684 3/20 0.55
RECQL P46063 1/20 0.55
HSD17B10 Q99714 1/20 0.47
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
ALOX12 P18054 1/20 0.45
MAPT P10636 4/20 0.43
GAA P10253 2/20 0.43
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31129888 0.86 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL11441783 0.86 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL508871 0.85 MAPT (0.51) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL17704660 0.85 ALDH1A1 (0.58) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL8295810 0.83 ALDH1A1 (0.56) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL1117240 0.82 TSHR (0.50) ALDH1A1TSHRCYP3A4MAPTHTT
SCHEMBL5913394 0.82 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL715634 0.81 ALDH1A1 (0.57) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL20707091 0.81 ALDH1A1 (0.55) ALDH1A1TSHRCYP3A4RECQLHSD17B10
SCHEMBL10662515 0.81 ALDH1A1 (0.55) ALDH1A1TSHRCYP3A4RECQLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110891951-A Compound (I) 谢菲尔德大学 2020-03-17 CN disclosed
US-9132130-B2 Purine derivative and antitumor agent using same ZENYAKU KOGYO KABUSHIKI KAISHA (JP) 2015-09-15 US disclosed
EP-2586778-A2 Pyridazinone derivatives useful as glucan synthase inhibitors Merck Sharp & Dohme Corp. (US) 2013-05-01 EP disclosed
US-20120088765-A1 PURINE DERIVATIVE AND ANTITUMOR AGENT USING SAME ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2012-04-12 US disclosed
CN-100584823-C Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL CO 2010-01-27 CN disclosed
EP-1385817-B1 MALONONITRILE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2008-12-03 EP disclosed
US-7402691-B2 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-22 US disclosed
CN-100376549-C Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL CO (JP) 2008-03-26 CN disclosed
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
CN-101033200-A Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL CO (JP) 2007-09-12 CN disclosed
US-7011838-B2 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-14 US disclosed
US-20050209323-A1 Malononitrile compounds and their use as pesticides OTAKA KEN 2005-09-22 US disclosed
CN-1639114-A Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL CO (JP) 2005-07-13 CN disclosed
US-20040138065-A1 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-15 US disclosed
EP-1385817-A2 MALONONITRILE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2004-02-04 EP disclosed
WO-2002090320-A2 MALONONITRILE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-11-14 WO disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209323-A1 Malononitrile compounds and their use as pesticides C1S, C1R, C5 ALDH1A1 1502/4885TSHR 2542/4885CYP3A4 304/4885
US-20040138065-A1 Malononitrile compounds and their use as pesticides CBR1, MAL2, CBR3 ALDH1A1 614/4885TSHR 3805/4885CYP3A4 343/4885
US-20120088765-A1 PURINE DERIVATIVE AND ANTITUMOR AGENT USING SAME PNP, TYMP, DPYD ALDH1A1 336/4885TSHR 4602/4885CYP3A4 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.